Ligand‐specific tuning of <scp>CLEC10A</scp> signalling strength and dendritic cell responses through engagement of different <scp>GalNAc</scp> ‐containing glycan structures

C-type lectin receptors on dendritic cells shape immune responses to pathogens and tumour cells through the specific recognition of glycans. C-type lectin domain family 10 member A [CLEC10A; also known as Macrophage Galactose-type Lectin (MGL)] binds terminal N-acetylgalactosamine (GalNAc) residues, which are often highly exposed on tumours. Signalling through this receptor increases Interleukin-10 (IL-10) and Tumour Necrosis Factor alpha (TNFα) production by monocyte-derived dendritic cells (moDCs), which promotes a T helper 2 (Th2) or type 1 regulatory T-cell (Tr1) response. Recently, several CLEC10A glycan ligands were identified that induce distinct conformational changes in the CLEC10A carbohydrate recognition domain, but their ability to alter moDC function has not been thoroughly explored. Here, we used CLEC10A ligand glycodendrimers to investigate the transcriptional responses induced by the CLEC10A ligands previously modelled and determined how these transcriptional programmes were associated with the cellular moDC responses. The CLEC10A ligand dendrimers varied in their affinity for CLEC10A and their capacity to increase IL-10 produced by moDCs. Although all glycodendrimers induced differential gene expression, this was strongest for the Forssman antigen dendrimer. The gene ontology (GO) terms associated with genes detected across ligands related to mitogen-activated protein kinase (MAPK) signalling, chemotaxis, apoptosis, angiogenesis, cytokine production and CD4<sup>+</sup> T-cell differentiation. The CLEC10A ligand dendrimers also altered the chemokine profile secreted by moDCs. Furthermore, these glycodendrimers increased the percentage of C-C Chemokine Receptor type 7 (CCR7)-expressing moDCs, which was prevented by inhibiting CLEC10A signalling. Overall, there was limited evidence for glycan-specific signalling via CLEC10A, but the glycans did alter the magnitude of the CLEC10A-mediated responses.

Authors

Institutions

Publication Details

Journal
FEBS Journal
Published
2025-11-16
DOI
https://doi.org/10.1111/febs.70317
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ligand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc ‐containing glycan structures

Yvette van Kooyk, Sandra J. van Vliet, R. J. Eveline Li, Tesfay M. Godefa et al.
FEBS Journal
Immunotherapy and Immune Responses
article

Ligand‐specific tuning of CLEC10A signalling strength and dendritic cell responses through engagement of different GalNAc ‐containing glycan structures

Yvette van Kooyk, Sandra J. van Vliet, R. J. Eveline Li, Tesfay M. Godefa, Nadia L. van der Meijs, Victor L. Thijssen, Rémi Hatinguais, Michael de Kok
article en

Abstract

C-type lectin receptors on dendritic cells shape immune responses to pathogens and tumour cells through the specific recognition of glycans. C-type lectin domain family 10 member A [CLEC10A; also known as Macrophage Galactose-type Lectin (MGL)] binds terminal N-acetylgalactosamine (GalNAc) residues, which are often highly exposed on tumours. Signalling through this receptor increases Interleukin-10 (IL-10) and Tumour Necrosis Factor alpha (TNFα) production by monocyte-derived dendritic cells (moDCs), which promotes a T helper 2 (Th2) or type 1 regulatory T-cell (Tr1) response. Recently, several CLEC10A glycan ligands were identified that induce distinct conformational changes in the CLEC10A carbohydrate recognition domain, but their ability to alter moDC function has not been thoroughly explored. Here, we used CLEC10A ligand glycodendrimers to investigate the transcriptional responses induced by the CLEC10A ligands previously modelled and determined how these transcriptional programmes were associated with the cellular moDC responses. The CLEC10A ligand dendrimers varied in their affinity for CLEC10A and their capacity to increase IL-10 produced by moDCs. Although all glycodendrimers induced differential gene expression, this was strongest for the Forssman antigen dendrimer. The gene ontology (GO) terms associated with genes detected across ligands related to mitogen-activated protein kinase (MAPK) signalling, chemotaxis, apoptosis, angiogenesis, cytokine production and CD4<sup>+</sup> T-cell differentiation. The CLEC10A ligand dendrimers also altered the chemokine profile secreted by moDCs. Furthermore, these glycodendrimers increased the percentage of C-C Chemokine Receptor type 7 (CCR7)-expressing moDCs, which was prevented by inhibiting CLEC10A signalling. Overall, there was limited evidence for glycan-specific signalling via CLEC10A, but the glycans did alter the magnitude of the CLEC10A-mediated responses.

FEBS Journal
Dutch Cancer Society (NL), Netherlands Center for Occupational Diseases (NL), Oncode Institute (NL), Cancer Genomics Centre (NL), Institute of Immunology (HR), Center for Translational Molecular Medicine (NL), Vrije Universiteit Amsterdam (NL)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Openalex Percentile: Top 63%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.